Projects

Corelation between 18-FDG PETCT quantitative parameters with clinicopathological features and survival outcomes in head and neck squamous cell carcinomas

Project Description

Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation. Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.

Project Duration

2025 - 2025

Project Lead

F Hadrian Noel Alexander

Authors

F Hadrian Noel Alexander

Project Status

ongoing

Project Type

Retrospective Cohort Study